Related Experiment Videos
Fas antigen expression in hepatocellular carcinoma tissues
1Department of Surgery II, Osaka University Medical School, Japan.
Oncology Reports
|April 4, 1998
Summary
Fas antigen expression decreases in advanced hepatocellular carcinoma (HCC). This loss of Fas is linked to poor differentiation, indicating a potential role in tumor progression.
Area of Science:
- Hepatobiliary pathology
- Cancer biology
- Immunology
Background:
- Fas antigen, a tumor necrosis factor receptor, induces apoptosis.
- Fas is highly expressed in hepatocytes, particularly during hepatitis.
- Its role in hepatocellular carcinoma (HCC) progression requires elucidation.
Purpose of the Study:
- To investigate the expression patterns of Fas antigen in HCC.
- To correlate Fas expression with various clinicopathological features of HCC.
Main Methods:
- Immunohistochemical analysis of Fas expression in 50 HCC samples.
- Correlation of Fas expression with differentiation, tumor thrombus, and invasion using univariate and multivariate analyses.
Main Results:
- Fas was expressed in non-cancerous hepatocytes and bile ducts.
- HCC showed reduced Fas expression in poorly differentiated tumors (p<0.001).
- Fas expression correlated inversely with differentiation (p=0.0002) and positively with tumor thrombus and invasion (p<0.05).
Conclusions:
- HCC expresses Fas antigen, similar to non-cancerous hepatocytes.
- Fas expression is lost during dedifferentiation as HCC advances.
- Reduced Fas expression may be a marker for HCC progression.